ATORVASTATIN — 20 YEARS IN THE STRUGGLE FOR LIFE

ATORVASTATIN — 20 YEARS IN THE STRUGGLE FOR LIFE

The efficacy and safety of atorvastatin discussed for the decrease of cardiovascular complications development.

Bibliographic Details
Main Author:	N. G. Gogolashvili
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2018-03-01
Series:	Российский кардиологический журнал
Subjects:	statins atorvastatin atherosclerosis cardiovascular diseases clinical trials
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2705

Similar Items

LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE
by: A. V. Susekov, et al.
Published: (2016-01-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

New clinical and pharmacological aspects of the use of atorvastatin for primary and secondary prevention of complications of cardiovascular diseases
by: S. R. Gilyarevsky, et al.
Published: (2018-09-01)

Atorvastatin in the secondary prevention of cardiovascular diseases
by: N. A. Vaulin
Published: (2014-12-01)

Statin therapy in atherosclerosis prevention: modern strategy and tactics
by: M. G. Bubnova
Published: (2009-06-01)

Atorvastatin: evidence base 15 years later
by: A. V. Susekov, et al.
Published: (2011-06-01)

Cost/effectiveness analysis of atorvastatin in patients with acute coronary syndromes
by: Simona Cammarota, et al.
Published: (2010-06-01)

The effectiveness of atorvastatin in the prevention of stroke
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

Atorvastatin, a double weapon in osteoporosis treatment: an experimental and clinical study
by: El-Nabarawy N, et al.
Published: (2017-05-01)

Effect of atorvastatin nanoparticles compared to free atrovastatin on plaque properties in rabbit model of atherosclerosis
by: Anjuman Arora, et al.
Published: (2019-01-01)

ATORVASTATIN IN ACUTE AND CHRONIC KINDS OF ISCHEMIC HEART DISEASE
by: V. E. Oleynikov, et al.
Published: (2015-11-01)

The Immunomodulatory Effects of Statins on Macrophages
by: Alanah Sheridan, et al.
Published: (2022-04-01)

STATINS IN PREVENTION OF ISCHEMIC STROKE
by: A. V. Susekov, et al.
Published: (2015-09-01)

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
by: Masadeh Majed, et al.
Published: (2012-05-01)

Aggressive statin therapy in acute coronary syndrome: therapeutic potential of atorvastatin in the daily dose of 80 mg
by: A. N. Britov
Published: (2009-12-01)

Statin-induced myopathy associated with atorvastatin therapy in the elderly patient. Clinical case
by: Natalia A. Cherkasova, et al.
Published: (2021-10-01)

Monacolin and atorvastatin in cardiovascular prevention – an attempt at positioning
by: Marcin Barylski
Published: (2017-03-01)

Atorvastatin blocks Sonic Hedgehog medulloblastoma progression through apoptosis
by: R.E. Gordon, et al.
Published: (2017-12-01)

Evaluation of Atorvastatin Safety on Liver Function Tests, a Prospective Study
by: Ramin Talaie, et al.
Published: (2015-07-01)

Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients
by: Saeed Kalantari, et al.
Published: (2014-01-01)

Use of Atorvastatin in Lipid Disorders and Cardiovascular Disease in Chinese Patients
by: Yi-Cong Ye, et al.
Published: (2015-01-01)

An atorvastatin‐induced positive anti‐HMGCR immune‐mediated necrotizing myopathy case
by: Nattanicha Chaisrimaneepan, et al.
Published: (2024-03-01)

Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome
by: Sh. A. Mostafa, et al.
Published: (2018-11-01)

Is the use of high-intensity atorvastatin associated with memory impairment?
by: Bharath raj kidambi, et al.
Published: (2022-01-01)

Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation
by: Sezer E, et al.
Published: (2011-06-01)

Atorvastatin plus compound probiotics in the treatment of hyperlipidemia： clinical trials
by: TIAN Yingjie*, WU Guang, WANG Honggui, REN Maojia, SONG Xiaopeng, CHANG Hao, GUO Zhixia, LI Xiaohong, BAI Xin, ZHAO Xingsheng
Published: (2023-05-01)

DYNAMICS OF MORPHOLOGICAL CHANGES IN BRACHIOCEPHALIC TRUNK ARTERIES INFLUENCED OF ATORVASTATIN THERAPY IN PATIENTS OF HIGH RISK
by: OA A Rubanenko
Published: (2018-09-01)

The Effect of Three-Month Atorvastatin and α-Calcidol Administration on Some Bone Tissue Morphometric Parameters
by: S. S. Asachuk, et al.
Published: (2021-07-01)

Effectiveness of Lipid-lowering Therapy for the Secondary Prevention and Achievement of Therapeutic Goals in Atherosclerotic Cardiovascular Diseases in Accordance with the American College of Cardiology/American Heart Association 2018 Guidelines on the Management of Blood Cholesterol
by: Christy Sojan, et al.
Published: (2024-04-01)

The effect of atorvastatin on inflammatory markers in sulfur mustard gas induced bronchitis: a randomized double-blinded, placebo-control clinical trial
by: Behrooz Momeni, et al.
Published: (2021-04-01)

Efficiency of atorvastatin on in-hospital mortality of patients with acute aortic dissection (AAD): study protocol for a randomized, open-label, superiority clinical trial
by: Yequn Chen, et al.
Published: (2021-04-01)

Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study
by: Guillermo Rodriguez-Nava, et al.
Published: (2020-07-01)

Identification and treatment of patients with high cardiovascular risk
by: I. V. Sergienko, et al.
Published: (1970-01-01)

Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon
by: Niaz Ali, et al.
Published: (2023-05-01)

Atorvastatin induced thrombocytopenia: A case report and review of literature
by: Saibal Moitra, et al.
Published: (2016-01-01)

A 12- week water aerobic exercise and atorvastatin effect on Changes of Atrial Natriuretic Peptide and Brain Natriuretic Peptide in older men with cardiovascular diseases
by: Mohsen Davoodi, et al.
Published: (2017-09-01)

Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy
by: A. D. Gavrilko, et al.
Published: (2023-11-01)

Effect of Atorvastatin on blood and gasometrical parameters in patients with COPD: A double-blind controlled clinical trial: Short Communication
by: Sayyed Gholamreza Mortazavi Moghadam, et al.
Published: (2016-11-01)

Effect of atorvastatin on delirium status of patients in the intensive care unit: a randomized controlled trial
by: Seyed Mojtaba Sohrevardi, et al.
Published: (2019-11-01)

ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING
by: A. V. Panov, et al.
Published: (2017-07-01)